Companies and People News for September 2018

Companies and People News Archive

Novel deep learning drug discovery platform gets £1 million innovation boost Novel deep learning drug discovery platform gets £1 million innovation boost

Optibrium, Intellegens and Medicines Discovery Catapult awarded funding to apply machine learning in drug discovery

MedPharm appoint Dr Jon Lenn and Dr Haydn Sinclair to Senior Scientific and Quality positions MedPharm appoint Dr Jon Lenn and Dr Haydn Sinclair to Senior Scientific and Quality positions

Leading topical and transdermal delivery specialist MedPharm Ltd have announced the appointments of Dr Jon Lenn to the position of Chief Technology Officer (CTO) and Dr Haydn Sinclair to the role of Vice President of Pharmaceutical Quality with Global Responsibilities.

Novel therapeutic strategy for blood vessel related disorders, such as cancer and retinopathy - Important international recognition for Peter Carmeliet Novel therapeutic strategy for blood vessel related disorders, such as cancer and retinopathy - Important international recognition for Peter Carmeliet

Blood vessels sustain health and proper functioning of our body. A multi-disciplinary team of scientists, led by prof. Peter Carmeliet (VIB-KU Leuven Center for Cancer Biology) has made several breakthrough discoveries concerning the metabolism of the individual building blocks of blood vessels - the so-called endothelial cells. They identified three key proteins that determine how blood vessels grow and behave, and that may become new therapeutic targets in blood vessel related disorders, such as life-threatening cancers and blinding eye diseases. For his pioneering research, Peter Carmeliet will receive the most prestigious international science prize, 2018 Heineken Prize for Medicine.